Performance Highlights - BeiGene (06160.HK) reported a revenue of 17.518 billion yuan for the first half of the year, a year-on-year increase of 46%; product revenue was 17.36 billion yuan, up 45.8%; net profit was 450 million yuan, turning from loss to profit [2] - Uni-President China (00220.HK) achieved approximately 17.087 billion yuan in revenue for the first half, a year-on-year increase of 10.6%; net profit was about 1.287 billion yuan, up 33.2% [2] - Zhiyu City Technology (09911.HK) announced a positive profit forecast, expecting mid-term revenue of approximately 3.135 to 3.215 billion yuan, a year-on-year increase of about 38.0% to 41.5%; net profit is expected to be around 470 to 510 million yuan, a year-on-year growth of approximately 108.9% to 126.7% [2] Earnings Forecasts - New World Development Company (00086.HK) expects mid-term net profit to increase to no less than 800 million HKD year-on-year [3] - Weizhi Jinkou (02003.HK) anticipates mid-term net profit exceeding 200 million HKD, a significant increase year-on-year [3] - Wing Chan Industrial (01596.HK) forecasts mid-term net profit of approximately 48.7 million HKD, turning from loss to profit [3] - Huaxian Optoelectronics (00334.HK) expects mid-term net profit to exceed 48.8 million HKD, a year-on-year increase of over 600% [3] - Maifushi (02556.HK) predicts mid-term net profit of approximately 31.8 to 41 million HKD, turning from loss to profit [4] - Xinwei Medical-B (06609.HK) expects mid-term net profit to exceed 40 million HKD, turning from loss to profit [5] - China Nuclear Technology (00611.HK) anticipates mid-term net profit growth of over 15% [6] Earnings Warnings - Hongxing Printing Group (00450.HK) expects mid-term net loss of approximately 49 million HKD, a significant increase year-on-year [7] - Zhongyu Land (01224.HK) forecasts mid-term net loss of approximately 40 million HKD, turning from profit to loss [7] - Beihai Group (00701.HK) anticipates mid-term net loss of 36 to 40 million HKD [8] Real Estate Sales Data - China Overseas Development (00688.HK) reported cumulative contract property sales of approximately 132 billion yuan for the first seven months, a year-on-year decrease of 18.3% [9] - Yuexiu Property (00123.HK) achieved cumulative contract sales of approximately 67.506 billion yuan for the first seven months, a year-on-year increase of about 11.7% [9] - Poly Property Group (00119.HK) reported contract sales of approximately 29.5 billion yuan for the first seven months, a year-on-year decrease of 13.49% [10] - China Overseas Hongyang Group (00081.HK) reported cumulative contract sales of 18.649 billion yuan for the first seven months, a year-on-year decrease of 12.2% [10] - Jindi Commercial Real Estate (00535.HK) reported cumulative contract sales of approximately 6.98 billion yuan for the first seven months, a year-on-year decrease of 37.37% [10] - Agile Group (03383.HK) reported pre-sale amount of approximately 5.69 billion yuan for the first seven months [11] - Hongyang Real Estate (01996.HK) reported cumulative contract sales of 3.208 billion yuan for the first seven months, a year-on-year decrease of 41.6% [12] - Zhengrong Real Estate (06158.HK) reported cumulative contract sales of approximately 2.701 billion yuan for the first seven months, a year-on-year decrease of 30.6% [12] - Jingrui Holdings (01862.HK) reported cumulative contract sales of approximately 571 million yuan for the first seven months, a year-on-year decrease of 52.54% [13] Company News - CITIC Securities (06030.HK) reported that its subsidiary, Huaxia Fund, achieved revenue of 4.258 billion yuan and net profit of 1.123 billion yuan in the first half, with assets under management totaling 285.1237 billion yuan [14] - Xinyi International (00732.HK) reported a cumulative operating revenue of approximately 9.566 billion HKD for the first seven months, a year-on-year decrease of about 5.3% [15] - Heng Rui Pharmaceutical (01276.HK) received orphan drug designation from the US FDA for its injection of Rikan Trastuzumab combined with Adebali for gastric cancer or gastroesophageal junction adenocarcinoma indications [15] - Fuhong Hanlin (02696.HK) completed the first patient dosing in a Phase II clinical study of HLX79 injection combined with Hanlikang® for active renal glomerulonephritis in China [15] - China Biopharmaceutical (01177.HK) announced that its self-developed TQ05105 (JAK/ROCK inhibitor) has been included in the breakthrough therapy designation program for the treatment of chronic graft-versus-host disease [15] Buyback Activities - HSBC Holdings (00005.HK) repurchased approximately 1.65 billion HKD worth of about 1.714 million shares at a price of 95.8 to 96.75 HKD [16] - Hang Seng Bank (00011.HK) spent approximately 22.6347 million HKD to repurchase 200,000 shares at a price of 112.8 to 113.6 HKD [17] - Yum China (09987.HK) repurchased approximately 6.264 million HKD worth of 16,800 shares at a price of 369.8 to 376 HKD [17]

公告深度解析增长动因：财务层面，因2024年5月成功登陆港交所，本期内可转换可赎回优先股公允价 值变动及上市费用归零，较去年同期大幅减少；业务层面，AI市场需求持续增长，直接拉动AI+SaaS业 务收入提升；同时，集团通过内部部署AI工具系统性优化运营流程，显著降低销售、管理及研发等"三 费"支出，进一步增强盈利能力。 8月6日，港股AI龙头企业迈富时(02556)披露盈利预喜公告。经初步评估，2025年上半年公司归属股东 净利润预计达人民币3180万元至4100万元，较去年实现强势逆转，成功扭亏为盈。 ...

相关事件 迈富时(02556.HK)预计上半年度将扭亏为盈 录得公司拥有人应占净利润约3180万元-4100万元 迈富时 (2556.HK)：AI推动SAAS与营销业务协同发展 迈富时释放成长潜力 格隆汇8月6日丨迈富时(02556.HK)公布，预期截至2025年6月30日止六个月将扭亏为盈，录得公司拥有 人应占净利润介于约人民币3180万元至人民币4100万元，去年同期公司拥有人应占净亏损约人民币 8.202亿元。 截至2025年6月30日止六个月，公司拥有人应占净利润的预期增长主要由于：(i)集团于2024年5月完成股 份在香港联合交易所上市，因此截至2025年6月30日止六个月上市费用及可转换可赎回优先股的公允价 值变动的影响为零，较去年同期大幅减少；(ii)2025年上半年AI市场需求增加，带动AI+SaaS业务收入持 续增长，使集团毛利增加；及(iii)集团内部应用AI工具，带来集团整体运营效率持续提升，致使销售费 用、行政费用及研发费用下降。 ...

邁 富 時 管 理 有 限 公 司 （ 於 開 曼 群 島 註 冊 成 立 的 有 限 公 司 ） （股份代號：2556） 內幕消息 盈利預告 本公告乃由邁富時管理有限公司（「本公司」，連同其附屬公司及其綜合聯屬實 體，統稱「本集團」）根據香港聯合交易所有限公司證券上市規則（「上市規則」）第 13.09(2)條及香港法例第571章證券及期貨條例第XIVA部內幕消息條文（定義見上 市規則）作出。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何 部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 Marketingforce Management Ltd 股東及潛在投資者於買賣本公司證券時務請審慎行事。 承董事會命 邁富時管理有限公司 董事長兼首席執行官 趙緒龍 香港，2025年8月6日 於本公告日期，本公司董事為：董事長、執行董事兼首席執行官趙緒龍先生、執行 董事許健康先生、非執行董事趙芳琪女士以及獨立非執行董事楊濤先生、秦慈先 生及陳晨先生。 本公司董事（「董事」）會（「董事會」）謹此知會本公司股東（「 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 邁富時管理有限公司 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02556 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 100,000,000,000 | USD | 0.0000005 | USD | | 50,000 | | 增加 / 減少 (-) | | | | | | USD | | | | 本月底結存 | | | 100,000,000,000 | USD | 0.0000005 | USD | | 50,000 | 本月底法定/註冊股本總額： USD 50,00 ...

东方证券指出，看好下半年垂类AI产品用户增长和商业化闭环提速，考虑到目前海外AI付费习惯和意 愿更好，该行认为应重视国内有海外AI应用布局的公司，商业化起量或超预期。中信证券此前表示， H20解禁有望提振头部厂商CAPEX投入节奏，叠加从模型迭代到应用爆发的多重催化，下半年AI主线 具备充分投资机遇。 消息面上，近期，AI应用迎来多重催化。7月26日，2025世界人工智能大会（WAIC 2025）在上海拉开 帷幕。具身智能、智能体、AI眼镜等AI应用方向获得了较高关注度。此外，阿里通义千问，智谱近日 相继发布最新大模型。阿里开源了通义千问最新的编程大模型Qwen3-Coder。该模型在代码能力和智能 体能力方面取得重大突破，超越GPT4.1等闭源模型，比肩全球最强的编程模型Claude4；智谱发布新一 代旗舰模型GLM-4.5，并在HuggingFace与ModelScope平台同步开源。此外，OpenAI计划于8月推出新版 旗舰大模型GPT-5。 智通财经APP获悉，AI概念股走势强劲，截至发稿，美图公司(01357)涨13.05%，报12.3港元；金蝶国际 (00268)涨9.92%，报18.4港元；汇量 ...

Industry Overview - The artificial intelligence agent industry in China is defined as software systems driven by large language models (LLMs) that integrate various plugins to make autonomous decisions and learn from their environment [1] - The industry has formed a complete system covering the foundational, technical, and application layers, with hardware and computing power providers at the base, model providers in the middle, and application developers and service providers at the downstream [2][5] Market Size and Growth - In 2023, the AI agent market in China reached 55.4 billion yuan, with projections to grow to 852 billion yuan by 2028, reflecting a compound annual growth rate (CAGR) of 72.7% [12] - The demand structure for AI agents is diverse and rapidly growing, with the intelligent customer service market exceeding 7 billion yuan in 2023 and expected to reach 18.13 billion yuan by 2027, a CAGR of over 27% [13] Development Trends - The AI agent industry is still in its early stages, evolving from simple chatbots to more complex agents capable of autonomous reasoning and decision-making [8] - The penetration rate of AI agents in enterprises is currently below 5% but is expected to rise to 25% for large enterprises and 15% for small and medium-sized enterprises by 2028 [15] Policy Background - Since 2015, the Chinese government has been promoting AI technology development and application through a comprehensive policy framework that includes ethical norms and data security [10][11] Competitive Landscape - The competitive landscape is characterized by a concentration of leading companies such as Alibaba, Tencent, and Baidu, which dominate the large model layer, while vertical players focus on specific industry applications [21][24] - Initial companies are leveraging technological breakthroughs and innovative models to disrupt the industry, with examples like Manus and Dify gaining significant traction [25] Future Outlook - The AI agent market is expected to experience significant growth, with industrial and medical applications showing strong potential due to the rapid release of smart manufacturing and automation needs [27] - Key technological breakthroughs in multi-modal interaction, autonomous decision-making, and multi-agent collaboration are critical for the industry's future development [30]

Summary of the Conference Call for 麦富时 Company Overview - 麦富时 operates in the SaaS and precision marketing services industry, with a current market capitalization of 15.4 billion HKD [2][4] - The company’s revenue structure consists of approximately 54% from SaaS and 46% from precision marketing services [6][15] Key Points and Arguments Revenue Growth Expectations - 麦富时 anticipates over 50% revenue growth in 2025, reaching approximately 2.3 to 2.4 billion CNY, driven by the introduction of AI modules and the launch of smart integrated machines [3][4] - The smart integrated machines are expected to contribute an additional 250 to 300 million CNY in revenue [3] Valuation Metrics - The current PS (Price to Sales) ratio is approximately 4.4x for 2026, with a PSG (Price to Sales Growth) of 0.1x [4] - The SaaS business has a PS ratio of about 8x, indicating a better value proposition compared to peers [4][18] Business Model and Product Offerings - The SaaS segment includes "真客" for large clients and "T 云" for SMEs, covering over 200,000 enterprises [2][6] - Precision marketing services have a lower gross margin of around 10% and include online advertising solutions [6] Competitive Advantages in AI SaaS - 麦富时 has established three competitive barriers: technology, ecosystem, and service [7][8] - The t force marketing model is specifically trained for marketing scenarios, enhancing customer engagement and reducing costs [8][9] Financial Performance and Future Outlook - From 2021 to 2024, total revenue grew from 880 million CNY to 1.56 billion CNY, with a stable CAGR [15] - Despite a slight decline in 2023 due to macroeconomic headwinds, the company expects a recovery with a projected 26.5% growth for the year [15][16] Profitability and Margin Improvement - 麦富时 achieved profitability in 2024, with expectations for net margins to improve to 6-7% in the coming years [16] - The shift in focus towards AI and SaaS is expected to enhance overall gross margins as the contribution from lower-margin precision marketing decreases [16] Market Positioning and Comparison with Competitors - 麦富时's products are positioned against international giants like Salesforce and Hubspot, with a focus on local market needs [10] - The company plans to expand into emerging markets in Southeast Asia, the Middle East, and Latin America, leveraging its cost-effective solutions [10] Valuation Considerations - Different valuation methods are suggested for various business segments, with the AI SaaS part expected to grow over 45% and warrant a PS of around 10x [17] - The precision marketing and smart integrated machine segments are suggested to be valued at PE ratios of 20x and 25x, respectively [17] Future Development in AI - 麦富时 is expected to benefit from advancements in AI technology and market expansion, with a potential for significant growth as the industry matures [21][22] - The company is recommended for continuous monitoring due to its promising position in the AI application sector [22] Additional Important Insights - The introduction of AI products has led to a 54.6% increase in monthly revenue per SaaS user by 2024 [8] - The smart integrated machine is designed for government and enterprise markets, enhancing operational efficiency significantly [9]

Core Insights - The narrative around large models has shifted towards enterprise-level AI Agents, focusing on the integration of AI into business processes and the creation of replicable, operational intelligent platforms [1] - Companies that can deliver measurable ROI through AI integration will be seen as the ultimate players in the market [1] Company Summaries 1. MaiFus (02556.HK) AI-Agentforce - MaiFus has focused on the "last mile" of enterprise AI application, emphasizing the concept of "delivery equals operation" for its AI-Agentforce platform, which highlights deployability, operability, and sustainable optimization [2] - The AI-Agentforce 2.0 integrates workflow orchestration, RAG knowledge engine, and DevOps lifecycle management, enabling efficient development and deployment of high-value AI applications [2] - The platform allows frontline staff to quickly generate and manage agents using natural language, reducing deployment barriers and accelerating AI application penetration within organizations [2][3] 2. ByteDance HiAgent - HiAgent is a highly platformized intelligent agent platform that aims to create a standardized, scalable operating system for AI agents, facilitating large-scale deployment and cross-scenario replication [4] - It features a unified agent orchestration framework that integrates a three-stage execution chain, supporting natural language, flowcharts, and API task flow construction [4] - HiAgent has been widely applied internally at ByteDance for tasks such as content review and customer service automation, and is gradually being offered as a SaaS product to external enterprises [4] 3. Dify - Dify is an active open-source intelligent agent platform that has gained traction in the GitHub community since its launch in 2023, primarily serving small and medium enterprises and AI developers [5] - The platform supports private deployment and a plugin ecosystem, allowing developers to build adaptable intelligent systems at low costs [5] - Dify is focused on creating a standardized open-source community to accelerate deployment efficiency for enterprises [5][6] Market Insights - MaiFus has chosen a challenging yet correct path by focusing on scene understanding, process re-engineering, and business closure rather than competing on computing power or model parameters [3] - HiAgent's strengths lie in its platform standardization and component-based development, which enhance system stability and reduce marginal costs for large-scale deployment [4] - Dify's lightweight platform is well-suited for sectors requiring private deployment, such as healthcare and government, due to its ease of deployment and strong controllability [6] Conclusion - The AI Agent market is diversifying, with companies like MaiFus focusing on value realization, while others like Baidu and Huawei pursue deep industry integration [7] - The ability to integrate AI with business processes and deliver measurable commercial value will determine the winners in this competitive landscape [7]

Investment Rating - The report assigns a "Buy" rating for the company, MaiFushi (2556.HK), marking its first coverage [1]. Core Insights - The AI + SaaS strategy drives MaiFushi's platform and integrated development path, significantly enhancing its competitive advantage [3][4]. - The company is positioned as a leading marketing and sales SaaS provider in China, with a projected revenue of 842 million yuan from AI + SaaS business in 2024, accounting for 54% of total revenue [3][4]. - The marketing SaaS market in China is expected to grow from 35.6 billion yuan in 2024 to 74.5 billion yuan by 2027, with a CAGR of 29.3% from 2022 to 2027, indicating substantial growth potential [4][28]. Summary by Sections Company Overview - MaiFushi, established in 2009, is a leading AI + SaaS intelligent marketing and sales cloud platform provider in China, headquartered in Shanghai with over 20 branches globally [13][14]. - The company has developed a "Six Cloud System" encompassing various services, integrating advanced multimodal large model technology to support businesses in achieving efficient customer acquisition and marketing automation [13][14]. Business Performance - The company has shown consistent revenue growth from 2021 to 2024, with 2024 revenue reaching 1.559 billion yuan, a year-on-year increase of 26.5% [49]. - The SaaS business has been a major driver of overall performance improvement, with user numbers and average monthly revenue per user increasing significantly [50][54]. Financial Projections - The projected net profit for the company from 2025 to 2027 is 2.05 million yuan, 113.42 million yuan, and 325.35 million yuan, respectively, with corresponding EPS of 0.01 yuan, 0.44 yuan, and 1.27 yuan [6]. - The company’s PE ratios for 2025, 2026, and 2027 are projected to be 7417.46, 133.76, and 46.63, respectively [6]. Market Dynamics - The marketing SaaS market is characterized by low penetration rates compared to the average for enterprise-level SaaS, indicating significant room for growth [28][29]. - The company has a strong customer base, with 80.9% of recurring revenue coming from large clients in 2024, showcasing its robust market presence [4][35]. Competitive Advantages - MaiFushi's integrated marketing services leverage high-quality media resources, strong advertising creativity, and data optimization capabilities, creating a comprehensive and intelligent marketing service system [5][37]. - The company differentiates itself from traditional advertising agencies through its data-driven technology barriers and strong customer retention [5][47].